Hybridoma clone 2G9C3 kit
Company
Bayer Corporation
Use
In vivo or in vitro use for detecting or treating human cancer
Features
Engineered to produce a desired antibody in large anounts
NIH Contribution
Developed hybridoma clone 2G9C3
HHS Institute/Agency
NCI
Inventor(s)
L. Varesio, S. Giardina, D. Longo
Year
1994
Tech Cat
Research Reagent
